Insider Trading & Ownership - MPM ONCOLOGY INNOVATIONS FUND LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for MPM ONCOLOGY INNOVATIONS FUND LP
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-03-27
Sale
2025-04-30
4:08 pm
Werewolf Therapeutics Inc.HOWLGADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM BioImpact LLC
MPM Oncology Innovations Fund GP LLC
MPM ASSET MANAGEMENT LLC
10% Owner
4,386$1.05$4,6056,718,670
(Indirect)
View
2021-05-04
Purchase
2021-05-06
4:19 pm
Werewolf Therapeutics Inc.HOWLGADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
245,000$16$3,920,0006,672,183
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion